A heteropolysaccharide, named L2, from Lentinula edodes has been proved to possess immunostimulating and anti-ageing activities in previous studies, but its acting mechanism was not completely understood. In this study,
INTRODUCTION
Different from other omics technologies (genomics, transcriptomics and proteomics), the metabolomics technique focuses on the changes of endogenous small molecular metabolites including amino acids, peptides, lipids, nucleic acids, organic acids, vitamins, etc. in biological samples [Monterio et al., 2013] . It is now widely used to identify various metabolic features associated with diseases, drug treatments or diet intervention [Gibbons & Brennan, 2017] . Nuclear magnetic resonance (NMR) and mass spectrometry (MS) are the primary techniques applied in metabolomics. Compared to MS, NMR provides most reliable structural and quantitative information of metabolites, but its sensitivity is low. In contrast, MS technique has high sensitivity, but it is sometimes confusing due to the discriminated ionization ability of different types of compounds and matrix effect [Pan & Raftery, 2007] . The commonly used pattern recognition methods in the metabolomics are principal component analysis (PCA) and partial least squares-discriminate analysis (PLS-DA). PCA and PLS-DA, as an unsupervised or supervised multivariable statistical method, respectively, are able to identify metabolites that differentiate between different samples [Worley et al., 2013] .
Lentinula edodes is one of the most popular edible mushroom in the world. Polysaccharides are found to be one of the most important components responsible for the bioactivities of L. edodes. In our previous studies, a new type of heteropolysaccharide, named L2, was obtained from the fruit body of L. edodes with an average molecular weight of 26 KDa but without triple-helix conformation [Xu et al., 2012] . In vitro, L2 increased the production of nitric oxide, tumor necrosis factor α, and interleukin 6 of RAW 264.7 cells in a wide range of pH circumstances with the involvement of toll-like receptor 2 [Xu et al., 2012] . Further studies demonstrated that L2 still exhibited immunostimulating activity by altering the spatial structure of gut microbiota and differentially affecting gene as well as protein expressions in adult mice [Xu & Zhang, 2015; Xu et al., 2015a; Xu et al., 2016] . Moreover, L2 displayed anti-aging activity by restoring the age-attenuated immune responses and partly reversing the age-related composition of gut microbiota [Xu et al., 2015b] . In order to better understand the acting mechanism of L2 and to further mine new functions of L2, NMR-based metabolomics approach was employed to investigate the urine metabolic profi les of the adult mice with L2 intervention.
MATERIAL AND METHODS

Animal protocols and materials
The detail processes of animal experiments were described in our previous report [Xu & Zhang, 2015] . Briefl y, fourteen 8-week specifi c pathogen-free male C57BL/6 mice were divided into the normal group (n=7) and the L2-treated group (n=6), respectively. Gavage administration of L2 (40 mg/kg 1 1 H NMR spectroscopy approach was employed to investigate the metabolic profi les of the urine from adult mice after L2 intervention. Using principal component analysis (PCA) and partial least squares-discriminate analysis (PLS-DA), 22 potential biomarkers were found to be mainly involved in some metabolic pathways: amino acid metabolism, energy metabolism, lipid metabolism, tricarboxylic acid (TCA) cycle, urea cycle and gut microbiota metabolism. Among them, the signifi cantly altered metabolites include: elevated glutamate (75%) and creatine (64%); decreased proline (65%), betaine (58%), fucose (63%) and dimethylamine (59%). In conclusion, the present data is helpful to understand the mechanisms related to previously confi rmed immunomodulation and anti-aging effects of L2, and provide valuable information for mining new functions of L2.
body weight) to L2-treated group for 28 consecutive days was performed. Experiments were approved by the Animal Care Welfare Committee of Guangzhou University of Chinese Medicine. Adequate measurements were applied to minimize the pain of animals. 24-hour urine samples were collected on the day before euthanasia by housing the mice in metabolic cages. Samples were centrifuged at 4000 rpm for 10 min at 4°C to remove particular contaminants and then stored at -70°C for further analysis.
Preparation of sample and acquisition of 1 H NMR spectroscopy Urine samples were fi rst defrosted (one sample was contaminated and excluded in L2-treated group) and then centrifuged at 5000×g for 10 min at 4°C. The supernatant (630 μL) was transferred into 5-mm NMR tubes and then 70 μL of Anachro Certifi ed DSS Standard Solution (ACDSS) (Anachro Technologies Inc., China) containing 5.0 mM 4,4-dimethyl-4-silapentane-1-sulfonic acid (DSS) was added according the manufacturer's instructions. All NMR spectra were recorded at 25°C on a Bruker AVANCE III-HD 600 MHz NMR spectrometer equipped with a 5mm PAQXI 1 H probe.
1
H NMR spectra were acquired using a one-dimensional NOESY (NoesyPr1d) pulse sequence (RD-90-t 1 -90-t m -90-ACQ) with water suppression during the relaxation delay of 10 s and a mixing time of 100 ms at the setting temperature of 298 K. For each urine sample, a total of 125 free induction decays (FID) were collected into 76724 data points at a fl ip angle of 90°, using a spectral width of 10,000 Hz, and an acquisition time of 4 s. FID was zero-fi lled to 64 K with an exponential function of a 0.5-Hz line-broadening factor prior to Fourier transformation.
Data pre-processing of NMR spectra and multivariate statistical analysis All NMR spectra were phased, corrected for baseline distortion, referenced to the methyl group of DSS at δ 0.000 and carefully aligned using the software of MestReNova 10.0.2 (Mestrelab Research S.L, Santiago de Compostela, Spain). The regions corresponding to residual water and urea, and DSS (4.5-6, and 0.0-0.5 ppm, respectively) were excluded in all spectra. The remaining regions of spectra were segmented into 0.01 ppm bins. The resulting integrals were then normalized to the total of the spectral area to partially compensate for differences in the concentrations of samples and converted to ASCII format. For metabolites identifi cation, NMR spectral data analysis was accomplished using targeted profi ling with Chenomx NMR Suite 4.6 (Chenomx Inc, Canada), which compares a known reference signal (DSS) with signals derived from a library of compounds containing chemical shifts and peak multiplicities and human metabolome database [HMDB] . The biofunction information of the identifi ed metabolites were derived from HMDB (http://www.hmdb.ca/).
Subsequently, the NMR spectral data were imported into SIMCA-P 12.0 software (Umetrics, Umeå, Sweden) for analysis and visualization by multivariate statistical methods. Data was mean-centered and Pareto-scaled to avoid NMR measurement noise prior to principal component analysis (PCA) and partial least squares discriminant analysis (PLS-DA) . 
Quantitative statistical analysis
Quantitative comparison of metabolites based on signal intensity in urine samples was done using a non-parametric one-way analysis of variance (Mann-Whitney test). The metabolites with high VIP (variable importance in projection) value in each PLS-DA model were selected for further analysis in two groups. Those variables with VIP value >1.0 and p<0.05 were considered as potential biomarkers. The potential biomarkers were further analyzed using integrating enrichment analysis and pathway topology analysis and visualization with MetaboAnalyst 3.0 (http://www. metaboanalyst.ca) [Xia et al., 2015] . Statistical signifi cance was considered at p<0.05. Statistical analyses were performed with SPSS 11.5.
RESULTS
H-NMR based metabolomics analysis
Metabolites in urine samples from normal and L2-treated group mice were profi led by 1 H-NMR and typical spectra of different samples were given in Figure 1 . A total of 35 compounds have been identifi ed, which include: (1) amino acids: leucine, isoleucine, valine, proline, methionine, lysine, glycine, N-acetylglutamic acid, etc.; (2) organic acids: lactate, propionate, citrate, malate, 2-oxoglutarate, succinate, etc.; (3) energy metabolites: creatine, creatinine, adenosine, etc.; (4) intestinal bacteria-metabolized products: dimethylamine(DMA), trimethylamine (TMA), phenylacetylglulamine, phenylacetylglycine, trimethylamine oxide (TMAO), hippurate, etc.; and (5) others: choline, glucose, fucose, etc.
Effect of L2 on urine metabolic profi ling
In order to compare metabolic profi ling between normal and treatment groups, the unsupervised PCA analysis was fi rstly used to visualize general clustering trends among the observations, and also to know whether the two groups could be distinguished based on their metabolic profi ling provided by NMR. The PCA scores plot ( Figure 2 ) showed that the separation between normal and treatment groups was not obvious. The fi rst two principal components accounted for 29.8% and 17.7% of the variance in NMR data, respectively. The parameters (R 2 X=0.474, Q 2 =0.0824, Q 2 <0.5) indicated low predictability for PCA model.
After PCA, supervised PLS-DA was applied to evaluate the systemic changes in the metabolomics of L2-treated mice, a PLS-DA model was established based on the data of normal and treatment groups. As shown in the scores plot (Figure 3 ), the two groups were clearly discriminated, which implied that mice from normal and L2 treatment had distinct urine metabolomic characteristics. The quality parameters of the PLS--DA model (R 2 X=0.506 and Q 2 =0.663, Q 2 >0.5) indicated that good separation of different groups was achieved, suggesting that biochemical changes happened in the urine of L2 treated group, and a reliable PLS-DA model was established. To visualize the importance of variables to the classifi cation, those variables with VIP values >1 were the mainly contributing metabolites and were shown in the loading plot ( Figure 4) . The farther to the origin, the greater the contribution to the classifi cation in the loading plot.
Identifi cation of potential biomarkers for L2 intervention
The changed metabolites, p-value below 0.05, were considered as candidate potential biomarkers. Based on this, 22 differential metabolites between normal and L2 treatment groups were identifi ed in urine samples (Table 1) , which were considered as potential biomarkers that correlated with how L2 infl uenced the physiological metabolism of adult mice. The VIP values of all the candidate metabolites in PLS-DA model were employed to determine their contribution to group separation. The altered metabolites with VIP value >1 in L2 treatment (Table 1) were mainly involved in amino acids (signifi cantly (p<0.05) increased levels of leucine, isoleucine, glutamate, glycine and phenylalanine, FIGURE 1. Representative 600 MHz 1 H NMR spectra of urinary samples obtained from normal mouse (A) and L2-treated mouse (B). Key for spectra: 1, isoleucine; 2, fucose; 3, arginine;4, 2-oxoglutarate;5, dimethylamine;6, citrulline; 7, proline; 8, phenylacetylglutamine; 9, leucine;10, adenosine; 11, trigonelline; 12, niacin; 13, benzoate; 14, lysine; 15, N-acetylglutamic acid; 16 but signifi cantly (p<0.01) decreased in proline, and citrulline (p<0.05)), metabolic products related to gut microbiota (increased in phenylacetylglutamine and phenylacetylglycine (p<0.05), but decreased in DMA, tartrate and benzonate (p<0.05)), organic acids (decreased in 2-oxoglutarate, malonic acid, and malate (p<0.05)), energy metabolism (increased in glucose and creatine (p<0.05), but decreased creatinine, trigonelline and niacin (p<0.05)), and phospholipids metabolism (decreased in betaine (p<0.05) as well as glycan and glycolipid metabolism (decreased in fucose (p<0.05)).
Perturbed metabolic pathway analysis
Based on the signifi cantly altered metabolite markers, more detailed analysis of pathways and networks regulated by L2 were performed using MetaboAnalyst data annotation approach. The multi-pathway metabolic perturbation associated with L2 treatment was summarized in Table 2 . Top 3 metabolic pathways of importance included amino acids synthesis and metabolism (glutamine and glutamate metabolism, glycine, serine and threonine metabolism, phenylalanine metabolism, phenylalanine, tyrosine and tryptophan biosynthesis), aminoacyl-tRNA biosynthesis (Raw p<0.05), and gut microbiota-related metabolism because fi ve identifi ed metabolites including DMA, phenylacetylglutamine, phenylacetyglycine, tartrate, and benzoate were cometabolites of the host and gut microbiota (notably, the gut microbiota-related metabolites not available in the database of MetaboAnalyst 3.0). 
DISCUSSION
Currently, not too much studies are available on the application of metabolomics method to the intervention effect and metabolism regulations of polysaccharides, especially for mushroom polysaccharides. For example, using biochemical parameters coupled with metabolomics based on gas chromatography-mass spectrometry (GC-MS), Ji et al. [2014] investigated the hepatoprotective effect of Angelica sinensis polysaccharides; employing an MS-based metabolomics approach, Wang et al. [2015] analyzed the serum and hepatic metabolic profi les of the mice with ethanol-induced liver injury and oral administration of Dendrobium huoshanense polysaccharide; while based on ultra-performance liquid chromatography quadrupole time-of-fl ight mass spectrometry (UPLC-Q-TOF/MS), Zhu et al. [2016] explored the effect of Ganoderma atrum-derived polysaccharide on the serum metabolites of type 2 diabetic rats. In this study, urine metabolomics profi ling was performed by NMR; the results revealed that L. edodes-derived polysaccharide L2 exposure dramatically altered a number of metabolic pathways including amino acid metabolism, tricarboxylic acid (TCA)/urea cycles, energy/lipid metabolism and gut microbiota-involved metabolism.
For amino acid metabolism, the relative concentrations of two branched chain amino acids (BCAAs) (leucine and isoleucine), glycine and phenylalanine were increased by 13-22%, in particular, 65% of reduction in proline and 75% of elevation in glutamate were observed in L2 treatment group in contrast to normal group. It was reported that BCAAs supplementation improved intestinal immune defense function by increasing intestinal immunoglobulins in weaned piglets [Ren et al., 2015] . BCAAs were also discovered to extend the life span of yeast [Alvers et al., 2009] and increase the average life span of male mice [D'Antona et al., 2010], suggesting that BCAA may play a role in aging process. Studies observed that the increases in BCAA were associated with anti-hyperlipidemia effect of a traditional Chinese medicine Xu-Fu-Zhu-Yu in rats [Song et al., 2013] , and the intervention of curcumin on hyperlipidemia mice also led to elevated levels of BCAA . Recently, the levels of BCAAs in serum were found to be associated with the gut bacterial species of Prevotella copri and Bacteroides vulgatus [Pedersen et al., 2016] . In particular, P. copri alone can increase the circulating levels of BCAAs in mice [Pedersen et al., 2016] . L2 exhibited altering the gut bacterial groups related to Prevotellaceae and Bacteroidaceae in mice [Xu & Zhang, 2015] , suggesting that the changed levels of BCAAs in the present study may be partially attributed to the alteration of gut microbiota composition. In addition, high serum phenylalanine concentration was found to be related to immune activation in patients with Alzheimer's disease [Wissmann et al., 2013] . Glycine administration was confi rmed to avoid the characteristic immunodefi ciencies in the experimentally diabetic rats [Lezcano Meza et al., 2006] . Proline was reported to be correlated to the degree of alcoholic liver injury [Lieber, 2000] . Previous study demonstrated that glutamate can amplify insulin release after its uptake into insulin granules mediated by cAMP/PKA signaling [Gheni et al., 2014] . Glutamate production is diminished in animal models of human diabetes and obesity, whereas in these models insulin secretion can be restored by a membrane-permeable glutamate precursor. In the present study, L2 remarkably increased the production of glutamate, suggesting potential of L2 in amplifying insulin secretion. Except amino acid transamination, glutamate is involved in a number of key functions in lymphocytes, macrophages and neutrophils. Glutamate is required as a precursor for ornithine synthesis in macrophages and monocytes. This pathway is linked to the urea cycle and ultimately results in formation of arginine, a substrate for inducible nitric oxide synthase. Glutamate may also serve as a precursor for glutathione synthesis, which may play a direct role in antioxidant defenses [Gleeson & Bishop, 2000] . Hence, based on the intervention effects of L2 on amino acids metabolism, it is pos- Note: s, singlet; d, doublet; t, triplet; q, quartet; m, other multiplet; dd, doublet of doublets. Bold letters indicated these peaks were visually assigned in Figure 1 . The arrows demonstrate that the metabolic change is signifi cantly increased (↑) or decreased (↓) in L2-treated mice compared to normal mice. The p values were analyzed using Mann-Whitney test based on the integrals of the selected peaks. *p<0.05, **p<0.01. Biofunction information derived from HMDB database. TCA, tricarboxylic acid. BCAA, branched chain amino acid.
sible that L2 could have potential benefi ts to immune function, anti-aging, anti-hyperlipidemia, ethanol-induced liver injury protection, insulin resistance improvement and antioxidant defense by altering the above amino acids metabolism. As a member of TCA cycle, the relative level of 2-oxoglutarate was decreased by 41% in response to L2 treatment. It was reported that the reduction of 2-oxoglutarate could be related to antioxidant activity, for it was depleted by scavenging hydrogen peroxide and converted to succinate [Long & Halliwell, 2011] . A recent study indicated that 2-oxoglutarate acted as a metabolic regulator of CD4(+) T cell differentiation by entering into the mitochondrial citric acid cycle [Klysz et al., 2015] . A decrease in the intracellular amount of 2-oxoglutarate shifted the balance between the generation of type 1 helper T cells and T regulatory (Treg) cells toward that of a Treg phenotype. Thus, there is a link between reduction of 2-oxoglutarate and immunomodulation.
For energy metabolism, the relative levels of creatinine, trigonelline and malonic acid were reduced by 25%, 31% and 38%, respectively, while the relative level of creatine was increased by 64%, in L2-treated group. [Perasso et al., 2013] .
In lipid metabolism pathway, the relative concentration of betaine was greatly decreased by 58% in L2-treated mice. In cells with vitamin B-6 defi ciency, >200% high concentration of betaine was observed [da Silva et al., 2014] . Manna et al. [2014] indicated that betaine was elevated in tumor tissue and urine from colorectal tumor-bearing mice. Ascha et al.
[2016] showed a signifi cantly high level of betaine in patients with alcoholic hepatitis (AH). Obi et al. [2016] reported that betaine was increased in aged venous thrombosis mice compared with young animals.
As the initial metabolite of the urea cycle, the relative level of citrulline was decreased by 26% after L2 treatment. It was reported that the level of citrulline was abundant in the elderly, suggesting an impaired urea cycle [Chaleckis et al., 2016] . Schoeman et al. [2016] pointed out that the progression of chronic hepatitis B virus (HBV) was associated with increased concentration of citrulline, refl ective of a dysregulated urea cycle in the HBV envelope antigen-negative phase.
In response to L2 intervention, the relative concentration of two monosaccharides was remarkably changed: fucose was reduced by 63%, but glucose was increased by 43%. Fucose was reported to be associated with intestinal infl ammation in a mouse model of Crohn's disease [Lin et al., 2010] . It is well established that glucose was of great importance in macrophage metabolism and activation [Bordbar et al., 2012] . High glucose concentration of LPS-stimulated macrophages was shown to increase NO production [de Souza et al., 2008] . Jung et al. [2013] reported that sera of asthma patients were characterized by decreased levels of glucose. Hence, the decreased fucose and the increased glucose could be helpful to infl ammation, immune activation, and asthma.
In gut microbiota-involved metabolism, 5 metabolites were perturbed: the relative levels of phenylacetylglulamine and phenylacetylglycine were increased by 13% and 15%, respectively; while tartrate, benzoate and dimethylamine (DMA) were decreased by 25%, 31% and 59%, respectively. Using a targeted metabolomics analysis, phenylacetylglutamine was identifi ed as a key gut microbiota-host co-metabolite in rat . By analyzing metabolite association with 16S gut microbiome profi les, Barrios et al. [2015] found that 52 Operational Taxonomic Units (OTUs) were signifi cantly associated with phenylacetylglutamine, and these microbial members belong to the order Clostridiales. Phenylacetylglutamine was considered to be a metabolic signature of extreme longevity in northern Italian centenarians: the increased excretion of phenylacetylglutamine in urine of centenarians [Collino et al., 2013] . As a gut microbial cometabolites [Yap et al., 2008] , the concentration of phenyl- The Total is the total number of compounds in the metabolic pathway; the Hits is the actually matched number from the identifi ed data; the Raw p is the original p value calculated from the enrichment analysis by MetaboAnalyst 3.0.
acetylglycine was increased in the urine metabolome of rats treated with N-carbamylglutamate (a compound for oxidative stress treatment) . Previous study showed that the metabolites: dimethylamine (DMA), trimethylamine (TMA), and trimethylamine oxide (TMAO), are derived only from symbiotic bacterial metabolism and not from mammalian metabolism in mice, for germ-free mice do not excrete TMA [al-Waiz et al., 1992] . Richards et al. [2013] indicated that an aging metabolic phenotype independent of diet was characterized by high levels of methylamine, DMA, TMAO and other metabolites in a lifelong dog, thus, the reduction of these metabolites could be helpful for anti-aging. Wu et al. [2008] found that many metabolites like DMA and TMAO were reset to younger levels in the rats, which was one potential mechanism for the anti-aging effects of the total fl avone of Epimedium. These results suggest potential benefi ts of L2 to oxidative stress treatment and anti-ageing by the altered microbiota-derived metabolites.
CONCLUSIONS
NMR-based metabolomics approach was successfully employed to analyze the alterations in the metabolic profi les of urine from adult mice treated with L. edodes-derived polysaccharide L2. Twenty two potential biomarkers were identifi ed, which were involved in a number of metabolic pathways: amino acids metabolism, energy metabolism, lipid metabolism, TCA cycle, urea cycle, glycolysis, gut microbiota metabolism, etc. The potential metabolic pathways or networks were structured in Figure 5 . The differentially changed metabolites can help to understand the acting mechanisms related to previously confi rmed immunomodulation and anti-aging activities of L2, and provide valuable information for mining new functions of L2. 
